Projects

Mgr. Andrea Zaťková, PhD.

International

Finished
  • FP7 Health: Clinical Development of Nitisinone for Alkaptonuria
    Program: FP7
    Duration: 1. 11. 2012 – 31. 1. 2019

National

Current
  • Study of the possibilities and limitations of the implementation of modern genetic analyses in clinical diagnostic procedures in patients without a clear and unambiguous clinical diagnosis
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • Testing the effectiveness of polygenic risk score calculations from whole genome sequencing data and evaluation of hereditary patterns of polygenic diseases
    Program: VEGA
    Duration: 1. 1. 2023 – 31. 12. 2025
Finished
  • Development and testing of molecular and informatic tools for effective characterisation and interpretation of clinically relevant microsatellite repetitive motifs from genomic data
    Program: SRDA
    Duration: 1. 7. 2019 – 30. 6. 2023
  • Study of alternative ways of genome-wide polygenic risk score calculations for the estimation of individual genetic predispositions to complex multifactorial diseases
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2022
  • Study of the genetic background of variable severity of Alkaptonuria using genomic approach.
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2022
  • Study of the potential role of selected genes in molecular pathogenesis of myotonic dystrophy
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Diagnostics of socially important disorders in Slovakia, based on modern biotechnologies
    Program: EU Structural Funds Research & Development
    Duration: 2. 11. 2010 – 31. 10. 2013
  • Diagnoses of Socially Important Diseases in Slovakia Based on Modern Biotechnologies.
    Program: EU Structural Funds Research & Development
    Duration: 1. 11. 2010 – 31. 10. 2013
Employees